Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Illumina
MedTech
Illumina faces EU's maximum fine for closing Grail deal: report
Illumina could face the maximum fine the European Commission can impose, totaling up to 10% of its annual revenues, according to a Reuters report.
Conor Hale
Jan 13, 2023 11:00am
Illumina lays off 5% of employees as sales forecasts falter
Nov 15, 2022 5:15pm
The Time 100: Tech influenced VC firm closes first $100M fund
Oct 26, 2022 11:08am
Illumina joins with AstraZeneca on AI drug discovery project
Oct 11, 2022 2:43pm
Illumina pitches $200 genomes with new line of DNA sequencers
Sep 30, 2022 12:06pm
EU blocks Illumina’s years-long quest for Grail
Sep 6, 2022 5:18pm
